Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Status:
Recruiting
Trial end date:
2026-09-22
Target enrollment:
Participant gender:
Summary
the investigators would like to compare the differences between roschvastin and atovastatin
in patients who require high-dose statin/ejetimib to undergo a new generation of drug elution
stent implantation for cardiovascular disease and maintain LDL cholesterol below 55 mg/dL.